Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2006-07-18
2006-07-18
Epps-Ford, Janet L. (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C435S320100, C435S325000, C435S091410, C435S091420, C435S455000
Reexamination Certificate
active
07078029
ABSTRACT:
The present invention provides an HSV having a genome with a mutation of a TAATGARAT sequence such that, in the presence of a ICP4 gene product, a native immediate early gene is expressed from the genome with delayed kinetics, the genome having a further inactivating mutation of each of the genes encoding ICP4.
REFERENCES:
patent: 5026635 (1991-06-01), Ferguson et al.
patent: 5070010 (1991-12-01), Hsu
patent: 5124263 (1992-06-01), Temin et al.
patent: 5658724 (1997-08-01), DeLuca
patent: 5672344 (1997-09-01), Kelley et al.
patent: 5674722 (1997-10-01), Mulligan et al.
patent: 5804413 (1998-09-01), DeLuca
patent: 0 453 242 (1991-10-01), None
patent: WO 95/13391 (1995-05-01), None
patent: WO 96/24663 (1996-08-01), None
Mackem et al., Journal of Virology, 44:939-949 (1982).
Misra V et al., Journal of Virology, 68:4898-4909 (1994).
Pizer Li et al., Nucleic Acids Research, 19:477-483 (1991).
Post Le et al., Cell 25:227-232 (1981).
Resnick J et al., ournal of Virology 63:2497-2503 (1989).
Batchelor et al.,Journal of Virology, 64(7), 3269-3279 (1990).
Breakefield et al.,The New Biologist, 3(3), 203-218 (1991).
Breakefield et al.,Treatment of Genetic Diseases, (Desnick ed.), 287-319 (1991).
Chiocca et al.,The New Biologist, 2(8), 739-746 (1990).
Croen et al.,New England Journal of Medicine, 317(23), 1427-1432 (1987).
DeLuca et al.,Journal of Virology, 56(2), 558-570 (1985).
DeLuca et al.,Nucleic Acids Research, 15(11), 4491-4511 (1987).
DeLuca et al.,Journal of Virology, 62(3), 732-743 (1988).
Dobson et al.,Journal of Virology, 63(9), 3844-3851 (1989).
Dobson et al.,Neuron, 5(3), 353-360 (1990).
Douville et al.,Virology, 207(1), 107-116 (1995).
Glorioso et al.,Seminars in Virology, 3(4), 265-276 (1992).
Goins et al.,Journal of Virology, 68(4), 2239-2252 (1994).
Ho et al.,Proceedings of the National Academy of Sciences of the United States of America, 86(19), 7596-7600 (1989).
Imbalzano et al.,Journal of Virology, 65(2), 565-574 (1991).
Johnson et al.,Journal of Virology, 65(5), 2952-2965 (1992).
Johnson et al.,Journal of Virology, 68(10), 6347-6362 (1994).
Kmetz et al.,Nucleic Acids Research, 16(10), 4735 (1988).
Krisky et al.,Gene Therapy, 5, 1593-1603 (1998).
Lokensgard et al.,Journal of Virology, 68(11), 7148-7158 (1994).
McCarthy et al. ,Journal of Virology, 63(1), 18-27 (1989).
Ngo et al.,The Protein Folding Problem and Tertiary Structure Prediction, (Merz et al. eds.), 434-506 (1994).
Orkin et al.,Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, 1-39 (1995).
Paterson et al.,Nucleic Acids Research, 16(23), 11005-11025 (1988).
Paterson et al.,Virology, 166(1), 186-196 (1988).
Post et al.,Cell, 25, 227-232 (1981).
Rivera-Gonzalez et al.,Virology, 202(2), 550-564 (1994).
Roizman et al.,Virology, (Fields ed.), 497-526 (1985).
Sacks et al.,Journal of Virology, 55(3), 796-805 (1985).
Sacks et al.,Journal of Virology, 61(3), 829-839 (1987).
Samaniego et al.,Journal of Virology, 69(9), 5705-5715 (1995).
Samaniego et al.,Journal of Virology, 71(6), 4614-4625 (1997).
Samaniego et al.,Journal of Virology, 72(4), 3307-3320 (1998).
Sears et al.,Journal of Virology, 55(2), 338-346 (1985).
Shepard et al.,Journal of Virology, 65(2), 787-795 (1991).
Shih et al.,Proceedings of the National Academy of Sciences of the United States of America, 81(18), 5867-5870 (1984).
Spector et al.,Journal of Virology, 3504-3513 (1991).
Walker et al.,Cell, 79(5), 841-852 (1994).
Werstuck et al.,Journal of Virology, 64(3), 984-991 (1990).
Wu et al.,Journal of Virology, 70(9), 6358-6369 (1996).
Shepard et al., “Separation of Primary Structural Components Conferring Autoregulation, Transactivation, and DNA-Binding Properties to the Herpes Simplex Virus Transcriptional Regulatory Protein ICP4,”Journal of Virology, 63(9): 3714-3728 (Sep. 1989).
Bandyopadhyay et al., “Expression from an Internal AUG Codon of Herpes Simplex Thymidine Kinase Gene Inserted in a Retrovirus Vector,”Molecular and Cellular Biology, 4(4): 743-748 (Apr. 1984).
Shepard et al., “Separation of Primary Structural Components Conferring Autoregulation, Transactivation, and DNA-Binding Properties to the Herpes Simplex Virus Transcriptional Regulatory Protein ICP4,”Journal of Virology,63(9): 3714-3728 (Sep. 1989).
Bandyopadhyay et al., “Expression from an Internal AUG Codon of Herpes Simplex Thymidine Kinase Gene Inserted in a Retrovirus Vector,”Molecular and Cellular Biology,4(4): 743-748 (Apr. 1984).
Epps-Ford Janet L.
Leavitt Maria
Leydig , Voit & Mayer, Ltd.
University of Pittsburgh of the Commonwealth System of Higher Ed
LandOfFree
Herpes simplex virus strains does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpes simplex virus strains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpes simplex virus strains will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3583757